A business in context

BNTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 6-K · Current report

    Report date 2026-08-28 · 0001776985-26-000061

  2. 6-K · Current report

    Report date 2026-08-27 · 0001776985-26-000059

  3. 6-K · Current report

    Report date 2026-08-20 · 0001776985-26-000057

  4. 6-K · Current report

    Report date 2026-06-30 · 0001776985-26-000055

  5. 6-K · Current report

    Report date 2026-08-04 · 0001776985-26-000054

  6. 6-K · Current report

    Report date 2026-08-03 · 0001776985-26-000051

  7. 20-F/A · Annual report

    Report date 2025-12-31 · 0001776985-26-000049

  8. 6-K · Current report

    Report date 2026-07-29 · 0001776985-26-000047

  9. 6-K · Current report

    Report date 2026-06-08 · 0001776985-26-000041

  10. 6-K · Current report

    Report date 2026-06-01 · 0001776985-26-000039

  11. 6-K · Current report

    Report date 2026-05-22 · 0001776985-26-000037

  12. 6-K · Current report

    Report date 2026-05-15 · 0001776985-26-000035

  13. 4 · Ownership change

    Report date 2026-05-12 · 0002123980-26-000005

  14. 4 · Ownership change

    Report date 2026-05-12 · 0002123971-26-000004

  15. 4 · Ownership change

    Report date 2026-05-12 · 0002123964-26-000006

  16. 4 · Ownership change

    Report date 2026-05-12 · 0002118987-26-000002

  17. 4 · Ownership change

    Report date 2026-05-12 · 0001955589-26-000004

  18. 6-K · Current report

    Report date 2026-05-07 · 0001776985-26-000033

  19. 6-K · Current report

    Report date 2026-03-31 · 0001776985-26-000031

  20. 6-K · Current report

    Report date 2026-05-05 · 0001776985-26-000030

  21. 4 · Ownership change

    Report date 2026-04-22 · 0001955589-26-000002

  22. 6-K · Current report

    Report date 2026-04-13 · 0001776985-26-000027

  23. 6-K · Current report

    Report date 2026-04-02 · 0001776985-26-000025

  24. 20-F/A · Annual report

    Report date 2025-12-31 · 0001776985-26-000023

  25. 6-K · Current report

    Report date 2026-03-24 · 0001776985-26-000021

  26. 20-F · Annual report

    Report date 2025-12-31 · 0001776985-26-000017

  27. 6-K · Current report

    Report date 2026-03-10 · 0001776985-26-000016

  28. 6-K · Current report

    Report date 2026-03-10 · 0001776985-26-000015

  29. 6-K · Current report

    Report date 2026-01-28 · 0001776985-26-000007

  30. 6-K · Current report

    Report date 2026-01-13 · 0001776985-26-000005

  31. 6-K · Current report

    Report date 2026-01-12 · 0001776985-26-000002

  32. 6-K · Current report

    Report date 2026-01-06 · 0001193125-26-003392

  33. 6-K · Current report

    Report date 2025-12-18 · 0001193125-25-324841

  34. 6-K · Current report

    Report date 2025-12-09 · 0001776985-25-000071

  35. 6-K · Current report

    Report date 2025-12-06 · 0001776985-25-000069

  36. 6-K · Current report

    Report date 2025-12-03 · 0001193125-25-306790

  37. 6-K · Current report

    Report date 2025-11-26 · 0001193125-25-300670

  38. 6-K · Current report

    Report date 2025-11-12 · 0001776985-25-000067

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 10 transaction rows10AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

11 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-12
2026-05-13
Zapata Gomez RamonA · Grant / award
Acquired
Option (right to buy)
Derivative security
18879.00.0
2026-05-12
2026-05-13
Zapata Gomez RamonA · Grant / award
Acquired
Performance Share Unit
Derivative security
15103.00.0
2026-05-12
2026-05-13
Jimenez KylieA · Grant / award
Acquired
Option (right to buy)
Derivative security
10488.00.0
2026-05-12
2026-05-13
Jimenez KylieA · Grant / award
Acquired
Performance Share Unit
Derivative security
8391.00.0
2026-05-12
2026-05-13
Ryan James Timothy PatrickA · Grant / award
Acquired
Performance Share Unit
Derivative security
10069.00.0
2026-05-12
2026-05-13
Ryan James Timothy PatrickA · Grant / award
Acquired
Option (right to buy)
Derivative security
12586.00.0
2026-05-12
2026-05-13
Hanekamp AnnemarieA · Grant / award
Acquired
Performance Share Unit
Derivative security
10069.00.0
2026-05-12
2026-05-13
Hanekamp AnnemarieA · Grant / award
Acquired
Option (right to buy)
Derivative security
12586.00.0
2026-05-12
2026-05-13
Poetting SierkA · Grant / award
Acquired
Performance Share Unit
Derivative security
10069.00.0
2026-05-12
2026-05-13
Poetting SierkA · Grant / award
Acquired
Option (right to buy)
Derivative security
12586.00.0
2026-04-22
2026-04-23
Poetting Sierk
10b5-1 checkbox reported
S · Sale
Disposed
Ordinary Shares50000.0110.56

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001776985BioNTech SE

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
894500UZJ5LG1F8J1U58
GLEIF legal name
BioNTech SE
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-09-02T13:46:12Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • BionTech · alias · wikidata
  • Biopharmaceutical New Technologies · alias · wikidata
  • BioNTech AG · alias · wikidata
  • BNT · alias · wikidata
  • BNTX · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗